Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Does a dedicated hip fracture unit improve clinical outcomes? A five-year case series.

Walton TJ, Bellringer SF, Edmondson M, Stott P, Rogers BA.

Ann R Coll Surg Engl. 2019 Mar;101(3):215-519. doi: 10.1308/rcsann.2018.0220. Epub 2019 Jan 3.

PMID:
30602304
2.

In-bore Multiparametric Magnetic Resonance Imaging Targeted Biopsy: As Good as it Gets?

Rosario DJ, Walton TJ, Kennish SJ.

Eur Urol. 2019 Apr;75(4):579-581. doi: 10.1016/j.eururo.2018.12.001. Epub 2018 Dec 15. No abstract available.

PMID:
30558900
3.
4.

Initial experience of an algorithm-based protocol for the community follow-up of men with prostate cancer.

Goodall PP, Little J, Robinson E, Trimble I, Cole OJ, Walton TJ.

BJU Int. 2017 Jan;119(1):67-73. doi: 10.1111/bju.13446. Epub 2016 Mar 12.

5.

Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study.

Nuhn P, Novara G, Seitz C, Gupta A, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Tritschler S, Martínez-Salamanca JI, Ficarra V, Karakiewicz PI, Mazzoleni G, Shariat SF, Bastian PJ.

World J Urol. 2015 Jul;33(7):1005-13. doi: 10.1007/s00345-014-1363-9. Epub 2014 Jul 22.

PMID:
25048439
6.

Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.

Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, Walton TJ, Wood CG, Bensalah K, Karakiewicz PI, Montorsi F, Margulis V, Shariat SF; French National Database on Upper Tract Tumors; Upper Tract Urothelial Carcinoma Collaboration.

J Urol. 2013 May;189(5):1662-9. doi: 10.1016/j.juro.2012.10.057. Epub 2012 Oct 24.

PMID:
23103802
7.

Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma.

Fajkovic H, Cha EK, Xylinas E, Rink M, Pycha A, Seitz C, Bolenz C, Dunning A, Novara G, Trinh QD, Karakiewicz PI, Margulis V, Raman JD, Walton TJ, Baba S, Carballido J, Otto W, Montorsi F, Lotan Y, Kassouf W, Fritsche HM, Bensalah K, Zigeuner R, Scherr DS, Sonpavde G, Roupret M, Shariat SF.

World J Urol. 2013 Feb;31(1):5-11. doi: 10.1007/s00345-012-0939-5. Epub 2012 Sep 26.

PMID:
23011256
8.

International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.

Roscigno M, Cha EK, Rink M, Seitz C, Novara G, Chromecki TF, Fritsche HM, Matsumoto K, Walton TJ, Carballido J, Filippo Da Pozzo L, Bertini R, Ficarra V, Otto W, Karakiewicz PI, Pycha A, Fajkovic H, Naspro R, Scherr DS, Montorsi F, Shariat SF.

BJU Int. 2012 Sep;110(5):674-81. doi: 10.1111/j.1464-410X.2012.10930.x. Epub 2012 Feb 20.

9.

Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.

Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V.

Eur Urol. 2012 Apr;61(4):818-25. doi: 10.1016/j.eururo.2012.01.021. Epub 2012 Jan 23.

PMID:
22284969
10.

Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.

Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W.

BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x. Epub 2011 Dec 16.

11.

Focal therapy for localised prostate cancer: are we asking the correct research questions?

Murphy DG, Walton TJ, Connolly S, Costello AJ.

BJU Int. 2012 Jan;109(1):1-3. doi: 10.1111/j.1464-410X.2011.10804.x. Review.

12.

The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.

Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS, Lotan Y, Raman JD, Kassouf W, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Walton TJ, Pycha A, Ficarra V, Karakiewicz PI, Zigeuner R, Pummer K, Shariat SF.

Eur Urol. 2012 Feb;61(2):245-53. doi: 10.1016/j.eururo.2011.09.017. Epub 2011 Sep 28.

PMID:
21975249
13.

Re: Miocinovic et al.: Avoiding androgen deprivation therapy in men with high-risk prostate cancer: the role of radical prostatectomy as initial treatment. (Urology 2011;77:946-950).

Connolly SS, Walton TJ, Cathcart PJ, Costello AJ, Murphy DG, Costello AJ, Murphy DG.

Urology. 2011 Sep;78(3):724-5; author reply 725. doi: 10.1016/j.urology.2011.05.039. No abstract available.

PMID:
21884924
14.

Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study.

Martinez-Salamanca JI, Shariat SF, Rodriguez JC, Chromecki TF, Ficarra V, Fritsche HM, Kassouf W, Matsumoto K, Cabello LO, Seitz C, Tritschler S, Walton TJ, Zattoni F, Novara G.

BJU Int. 2012 Apr;109(8):1155-61. doi: 10.1111/j.1464-410X.2011.10479.x. Epub 2011 Aug 24.

15.

Renal cell carcinoma: stage, grade and histology migration over the last 15 years in a large Australian surgical series.

Walton TJ, Cathcart PJ, Connelly SS, Costello AJ, Murphy DG.

BJU Int. 2011 Aug;108(4):E155-6. doi: 10.1111/j.1464-410X.2011.10536_2.x. No abstract available.

16.

Re: Bayan Alsaid, Thomas Bessede, Djibril Diallo, et al. Division of autonomic nerves within the neurovascular bundles distally into corpora cavernosa and corpus spongiosum components: immunohistochemical confirmation with three-dimensional reconstruction. Eur Urol 2011;59:902-9.

Murphy DG, Walton TJ, Cathcart PJ, Connolly SS, Costello AJ.

Eur Urol. 2011 Sep;60(3):e19-20; author reply e21-2. doi: 10.1016/j.eururo.2011.05.058. Epub 2011 Jun 12. No abstract available.

PMID:
21684065
17.

No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study.

Burger M, Shariat SF, Fritsche HM, Martinez-Salamanca JI, Matsumoto K, Chromecki TF, Ficarra V, Kassouf W, Seitz C, Pycha A, Tritschler S, Walton TJ, Novara G.

World J Urol. 2011 Aug;29(4):465-72. doi: 10.1007/s00345-011-0705-0. Epub 2011 Jun 1.

PMID:
21630120
18.

Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.

Matsumoto K, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M, Ng C, Kikuchi E, Zigeuner R, Kassouf W, Fritsche HM, Ficarra V, Martignoni G, Tritschler S, Rodriguez JC, Seitz C, Weizer A, Remzi M, Raman JD, Bolenz C, Bensalah K, Koppie TM, Karakiewicz PI, Wood CG, Montorsi F, Iwamura M, Shariat SF.

BJU Int. 2011 Oct;108(8 Pt 2):E304-9. doi: 10.1111/j.1464-410X.2011.10188.x. Epub 2011 Apr 20.

19.

Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.

Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Bastian PJ, Martínez-Salamanca JI, Scherr DS, Shariat SF.

World J Urol. 2011 Aug;29(4):473-80. doi: 10.1007/s00345-011-0677-0. Epub 2011 Apr 17.

PMID:
21499902
20.

Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients.

Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G.

World J Urol. 2011 Aug;29(4):487-94. doi: 10.1007/s00345-011-0645-8. Epub 2011 Jan 20.

PMID:
21249372
21.

Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort.

Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF.

BJU Int. 2011 Aug;108(3):406-12. doi: 10.1111/j.1464-410X.2010.09826.x. Epub 2010 Nov 15.

22.

Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma.

Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G.

World J Urol. 2011 Aug;29(4):481-6. doi: 10.1007/s00345-010-0594-7. Epub 2010 Oct 1.

PMID:
20886219
23.

Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study.

Seitz C, Gupta A, Shariat SF, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Otto W, Tritschler S, Bastian PJ, Carballido J, Ficarra V, Karakiewicz PI, Artibani W, Mazzoleni G, Novara G.

J Urol. 2010 Nov;184(5):1895-900. doi: 10.1016/j.juro.2010.06.106. Epub 2010 Sep 17.

PMID:
20846680
24.

Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study.

Novara G, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Bastian PJ, Martínez-Salamanca JI, Seitz C, Lemberger RJ, Burger M, El-Hakim A, Baba S, Martignoni G, Gupta A, Karakiewicz PI, Ficarra V, Shariat SF.

Eur Urol. 2010 Jun;57(6):1064-71. doi: 10.1016/j.eururo.2009.12.029. Epub 2010 Jan 6.

PMID:
20071073
25.

Imaging after medically managed severe acute cholecystitis.

Walton TJ, Dhingsa R, Kaye PV, Lobo DN.

Gut. 2009 Mar;58(3):421, 472. doi: 10.1136/gut.2008.164970. No abstract available.

PMID:
19211856
26.

Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.

Walton TJ, Li G, McCulloch TA, Seth R, Powe DG, Bishop MC, Rees RC.

Prostate. 2009 Jun 1;69(8):810-9. doi: 10.1002/pros.20929.

PMID:
19189301
27.

Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.

Walton TJ, Sherwood BT, Parkinson RJ, Obakponovwe O, Thomas SA, Taylor MC, England RC, Lemberger RJ.

J Urol. 2009 Feb;181(2):532-9. doi: 10.1016/j.juro.2008.10.032. Epub 2008 Dec 13.

PMID:
19084866
28.

An improvised delivery system for irrigation.

Walton TJ, Heads S, Parkinson RJ, Griffiths TR.

Ann R Coll Surg Engl. 2008 Jul;90(5):429-30. No abstract available.

29.
30.

Aggressive renal cell carcinoma in a 27-year-old kidney transplant.

Walton TJ, McCulloch TA, Bishop MC.

Nephrol Dial Transplant. 2005 May;20(5):1018-9. Epub 2005 Mar 15. No abstract available.

PMID:
15769819
31.
32.

Seamless training must work for Research Fellows.

Walton TJ.

BJU Int. 2004 Jul;94(1):194. No abstract available.

33.
34.
35.

Advanced renal cell carcinoma in the absence of a mass.

Walton TJ, Stanley JC, Davies RJ, Cohen RJ.

ANZ J Surg. 2001 Jun;71(6):388-90. No abstract available.

PMID:
11409029
36.
37.

Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice.

Rodgers RJ, Haller J, Holmes A, Halasz J, Walton TJ, Brain PF.

Physiol Behav. 1999 Dec 1-15;68(1-2):47-53.

PMID:
10627061
38.

Kinetic analysis of cyclic CMP-specific and multifunctional phosphodiesterases by quantitative positive-ion fast-atom bombardment mass spectrometry.

Newton RP, Bayliss MA, Khan JA, Bastani A, Wilkins AC, Games DE, Walton TJ, Brenton AG, Harris FM.

Rapid Commun Mass Spectrom. 1999;13(7):574-84.

PMID:
10230067
39.

Fast-atom bombardment tandem mass spectrometry of cyclic nucleotide analogues used as site-selective activators of cyclic nucleotide-dependent protein kinases.

Walton TJ, Bayliss MA, Pereira ML, Games DE, Genieser HG, Brenton AG, Harris FM, Newton RP.

Rapid Commun Mass Spectrom. 1998;12(8):449-55.

PMID:
9586232
40.

K+ induces an acid-labile phosphoenzyme (or an occluded Pi form) in Na,K-ATPase.

Cavieres JD, Buxbaum E, Ward DG, Walton TJ.

Ann N Y Acad Sci. 1997 Nov 3;834:381-5. No abstract available.

PMID:
9405830
41.

Kinetic analysis and multiple component monitoring of effectors of adenylyl cyclase activity by quantitative fast-atom bombardment mass spectrometry.

Newton RP, Bayliss MA, van Geyschem J, Harris FM, Games DE, Brenton G, Wilkins AC, Diffley P, Walton TJ.

Rapid Commun Mass Spectrom. 1997;11(9):1060-6.

PMID:
9204579
42.

Estimation of cytidylyl cyclase activity and monitoring of side-product formation by fast-atom bombardment mass spectrometry.

Newton RP, Groot N, van Geyschem J, Diffley PE, Walton TJ, Bayliss MA, Harris FM, Games DE, Brenton AG.

Rapid Commun Mass Spectrom. 1997;11(2):189-94.

PMID:
9050266
43.

Analysis by gas chromatography-mass spectrometry of the fatty acid composition during temperature adaptation in Aphanizomenon flos-aquae, a diazotrophic cyanobacterium from the Baltic Sea.

Evans AM, Li D, Jones A, Games MP, Games DE, Gallon JR, Walton TJ.

Biochem Soc Trans. 1996 Aug;24(3):475S. No abstract available.

PMID:
8879019
44.

Assay of adenylyl cyclase activity by quantitative mass spectrometry.

el-Shazley H, Newton RP, Harris FM, Brenton AG, Walton TJ, Restall CJ, Bayliss M, Wilkins A, Games DE, Langridge JI.

Biochem Soc Trans. 1996 Aug;24(3):474S. No abstract available.

PMID:
8879018
45.

Inositol lipid signal transduction in phytoalexin elicitation.

Walton TJ.

Biochem Soc Trans. 1995 Nov;23(4):862-7. Review. No abstract available.

PMID:
8654854
46.

Assay of adenosine 3',5'-cyclic monophosphate-dependent protein kinase activity by quantitative fast atom bombardment mass spectrometry.

Newton RP, Evans AM, Langridge JI, Walton TJ, Harris FM, Brenton AG.

Anal Biochem. 1995 Jan 1;224(1):32-8.

PMID:
7710089
47.

Effect of dietary cholesterol on membrane properties and immune functions in rainbow trout.

Bowden LA, Weitzel B, Ashton IP, Secombes CJ, Restall CJ, Walton TJ, Rowley AF.

Biochem Soc Trans. 1994 Aug;22(3):339S. No abstract available.

PMID:
7821595
48.

A Ca2+/phospholipid dependent protein kinase from suspension cultures of lucerne.

Robinson P, Newton RP, Walton TJ, Smith CJ.

Biochem Soc Trans. 1994 Aug;22(3):307S. No abstract available.

PMID:
7821566
49.

Irreversible effects of calcium ions on the plasma membrane calcium pump.

Ward DG, Walton TJ, Cavieres JD.

J Membr Biol. 1993 Dec;136(3):313-26.

PMID:
8114081

Supplemental Content

Loading ...
Support Center